$HHSE Hannover House forms InteliMation AI for first major

New Post Public Reply Private Reply Replies (1) Message Board
louied91
245
$HHSE Hannover House forms InteliMation AI for first major A.I. Animated Feature Production

https://www.accesswire.com/784381/hannover-ho...production

JOURNEY TO UTOPIA to begin production in December with A-List Voice & Music Talent

Major launch planned for Cannes and Summer (2024) Theatrical Release

NEW YORK, NY / ACCESSWIRE / September 15, 2023 / InteliMation AI, a newly formed division of indie studio Hannover House, Inc. (OTC PINK:HHSE), has secured a private investment commitment to produce the world's first fully A.I. and CGI generated feature film, the family appeal fantasy film, "Journey to Utopia." Featuring a voice talent cast of Academy Award winning actors and box office stars, the film's visuals will be fully generated using cutting-edge Artificial Intelligence visual rendering, based on producer-supplied scene structure input and character designs.

"We have been trying to produce this film for the past ten years," said Eric Parkinson, C.E.O. of Hannover House. "But the visual demands of creating the land of Utopia made the production costs prohibitive and financially risky. That has changed now with the new A.I. technology and our improved strategy to make the film animated as opposed to live-action," he concluded.

"The Artificial Intelligence CGI technology has reached a point where we can create an animated feature that is visually comparable to a $200-million-dollar studio production, but completed for a fraction of the cost and time," said Parkinson. "From script to theatrical DCP, we can produce a major studio quality animated feature in less than eight months."

"The technology from InteliMation should herald in a major paradigm shift in entertainment," said Christian Large, an independent producer and advisor to Hannover House. "High-end animated features will no longer take multiple years and hundreds-of-millions of dollars to produce. This technological breakthrough will enable a broader range of stories to be created and released, which ultimately will help expand the market," he concluded.

The script for "JOURNEY TO UTOPIA" was written by Mike Snyder ("Wildfire" based on a story by Eric Parkinson. The production is in negotiations to secure three Academy Award winning actors as voice talent for the film. Shirley MacLaine is pegged for the role of "Mother Goose;" Forest Whitaker is being pursued to portray the principal antagonist, "Valkerna," and Kim Basinger is being pursued in the role of "Connie Hammonds," the mother of one of the kids who becomes trapped in the land of Utopia.

Pending receipt of a Screen Actors Guild waiver for the production, recording of voice talent is expected to start in late November or early December. A promo reel is planned for the Cannes 2024 festival with a USA Theatrical launch targeted for July 2024.

The world animation market will generate over $411-billion dollars in 2023, according to Statista Research Department - and is expected to grow to over $580-billion by the year 2030. The A.I. fueled software technology pioneered by Hannover House and InteliMation will revolutionize how animated features and television programming are made.

Hannover House and InteliMation are targeting to complete two animated features in 2024, with three set for 2025 and four features per year beginning in 2026. Hannover House will handle the sales representation of the films worldwide, and will coordinate North American theatrical and ancillary sales campaigns with exhibitors, partner studios and major video-on-demand platforms. Hannover House was formed in 1993 and has found success in a variety of indie film distribution arenas, from DVD and VOD distribution to theatrical exhibition.

The release plans for "Journey To Utopia" will follow a traditional model of a wide USA theatrical launch, followed by Video-On-Demand and physical goods (DVDs / BluRay units).
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Expanding Horizons: Future of IVD Contract Manufacturing

Updated Category News Views 117

The Growing Landscape of IVD Contract Manufacturing The in vitro diagnostics (IVD) contract manufacturing market is on the brink of significant expansion, anticipated to reach a staggering USD 39.74 billion by 2031. This growth represents a compounded annual growth rate (CAGR) of 11.60% from 2024 to 2031, driven chiefly by the needs of the healthcare industry to keep pace...

Continue Reading
Citi Upgrades AerCap Holdings Price Target to $117 Amid Strong Performance

Updated Category News Views 79

Citi Upgrades AerCap Holdings Price Target Citi has recently updated its outlook on AerCap Holdings (NYSE:AER), raising the price target to $117 from $113. This move reflects Citi's confident stance on the aircraft leasing company's financial health within the aviation sector. By reaffirming their buy rating, the firm signals strong expectations for AerCap's growth...

Continue Reading
LG Energy Solution Reports Strong Q2 2025 Financial Performance

Updated Category News Views 750

LG Energy Solution Achieves Remarkable Financial Milestones In a significant announcement, LG Energy Solution has revealed its performance for the second quarter of 2025, detailing impressive results that demonstrate the company's resilience and strategic focus on growth. With consolidated revenue of KRW 5.6 trillion and an operating profit of KRW 492.2 billion, the...

Continue Reading
Genpact Shines as a Leader in Sustainability Recognition

Updated Category News Views 264

Genpact's Sustainable Initiatives Gain Global Recognition Recently, Genpact (NYSE: G), an advanced technology services provider, received significant acclaim for its commitment to sustainability. Being featured in TIME's prestigious list of the World's Best Companies in Sustainable Growth for 2025 showcases their dedication to ethical business practices and innovation. A...

Continue Reading
Medical Express Ambulance Faces Data Breach Investigation

Updated Category News Views 344

Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....

Continue Reading